HONS 182 Neuroethics – Spring 2005

Organization of topics

August 1, 2005

Schedule

 

1.         The new field of neuroethics

            a.         William Safire is credited with coining the term neuroethics.

            b.         Kennedy D. Neuroscience and neuroethics. Science. 2004 Oct 15;306(5695):373.

            c.         Farah MJ. Emerging ethical issues in neuroscience. Nat Neurosci. 2002 Nov;5(11):1123-9.

                        i.         http://www.upenn.edu/pennnews/article.php?id=727

            d.         Sententia W. Neuroethical considerations: cognitive liberty and converging technologies for improving human cognition. Ann N Y Acad Sci. 2004 May;1013:221-8.

            e.         Moreno JD. Neuroethics: an agenda for neuroscience and society. Nat Rev Neurosci. 2003 Feb;4(2):149-53.

            f.         Dana Foundation

                        i.         http://www.dana.org/books/press/neuroethics/

            g.         University of Pennsylvania

                        i.         http://www.neuroethics.upenn.edu/ [Great listing]

            h.         President's Council on Bioethics

                        i.          http://www.bioethics.gov/topics/neuro_index.html

            i.         Center for Cognitive Liberty & Ethics

                        i.         http://www.cognitiveliberty.org/index.html

            j.         Stanford University

                        i.         http://scbe.stanford.edu/research/programs/neuroethics.html

            k.         Scientific American editorial

            l.           NIH's Bioethics Resources on the Web


2.         Scientific method

            a.         Strong inference

                        i.         Platt, J.R. 1964: Strong inference. Science 146,347-353

            b.         Method of multiple hypotheses

                        i.         Chamberlain, T.C. 1965: The method of multiple workinghypotheses. Science, 148, 754-759

            c.         Converging operations and quality of data

                        i.         Ambiguity of single trials and individual subjects

                        ii.        Necessity of agreement between different kinds of data

            d.         Side effects & unexpected consequences

                        i.         Edward Tenner, WHY THINGS BITE BACK: Technology and the Revenge of Unintended Consequences
(346 pp. Alfred A. Knopf, 0-679-42563-2)

 

3.         Mind-brain relations

            a.         Basics of brain function

                        Neuroscience. by Purves, Dale; Augustine, George J.; Fitzpatrick, David; Katz, Lawrence C.; LaMantia, Anthony-Samuel; McNamara, James O.; Williams, S. Mark Sunderland (MA): Sinauer Associates, Inc.; 2001.

            b.         Linking mental and neural function

                        i.         Tom Wolfe, Sorry, But Your Soul Just Died

                        ii.        Schall JD. On building a bridge between brain and behavior. Annu Rev Psychol. 2004;55:23-50.

            c.         Free will, determinism & decision making

                        i.         Some resources
(1)       Schall JD. Decision making. Current Biology  2005. 15:R9-R11.

                                    (1)       Schall JD. Neural basis of deciding, choosing and acting. Nat Rev Neurosci. 2001 Jan;2(1):33-42.

                                    (2)       Schall JD, Thompson KG. Neural selection and control of visually guided eye movements. Annu Rev Neurosci. 1999;22:241-59.

                                    (3)       Schall JD, Stuphorn V, Brown JW. Monitoring and control of action by the frontal lobes. Neuron. 2002 Oct 10;36(2):309-22

                        ii.        Issues

                                    (1)       Prisoner’s dilemma

                                    (2)       Newcomb’s paradox

                                    (3)       Can the brain be manipulated to eliminate appreciation of ethical dilemma?

            d.         Brain basis of personality

                        i.         Neural basis of judgment and moral reasoning

                                    ii.        Anderson SW, Bechara A, Damasio H, Tranel D, Damasio AR. Impairment of social and moral behavior related to early damage in human prefrontal cortex. Nat Neurosci. 1999 Nov;2(11):1032-7.

                                    iii.       Greene JD, Sommerville RB, Nystrom LE, Darley JM, Cohen JD. An fMRI investigation of emotional engagement in moral judgment. Science. 2001 Sep 14;293(5537):2105-8.

                        iv.       Split brain

                                    (1)       Turk DJ, Heatherton TF, Macrae CN, Kelley WM, Gazzaniga MS. Out of contact, out of mind: the distributed nature of the self. Ann N Y Acad Sci. 2003 Oct;1001:65-78.

4.         Diagnosis & treatment of neurological and psychological disorders

The Science of Mental and Neurological Disorders

 

Discussing the biology of mental and neurological disorders is quite an undertaking.  In fact, an entire semester of university credit is devoted to it in Vanderbilt’s psychology course entitled the Biological Basis of Mental Disorders.  Thus said, there is obviously no way to do the subject justice in one class period.  What we did attempt to undertake, however, is a brief description of the biology behind depression.  We used this as a springboard for a larger discussion on the ethics of mental disorders and the ethics of medications that treat depression, such as Prozac.  Is depression overdiagnosed?  Can a person without depression take Prozac and become happier?  Can a pill become the panacea for eliminating any feelings of pain or suffering? These are some of the questions pondered in relation to the topic.  Many of the questions that come to mind were not addressed in class, but will help the observer to think about this subject in a critical manner.

 

The most recent hypothesis for the biological basis of depression that has been supported by the most evidence is the theory which implicates the hyperactivity of the HPA axis as the cause of depression.  The prefrontal cortex sends messages regarding its perceptions to the amygdala and the hypothalamus, some of the emotional processing centers of the brain.  In this schematic, the amygdala serves as a “revving up” of the hypothalamus and the resulting stress response while the hippocampus serves as a “calming down” of the hypothalamus and the stress response.  The stress response involves the release of corticotropin-releasing hormones, which prompts the release of adrenocorticpotropin hormone.  This travels through the blood as a hormone to the adrenal gland of the kidney and prompts the release of corticosteroids.  Normally, these corticosteroids that are released as a result of the stress response would travel through the body, attach to glucocorticoid receptors on the hippocampus, and activate the downregulation of the stress response.  Various theories exist as to why this does not happen, but somehow the binding on the hippocampus does not occur and the HPA axis is continually upregulated without being brought back down to resting state by the hippocampus.  The theory suggests that depression is a mood disorder regulated by stress and inherently tied to anxiety.

 

We discussed whether or not we believed that depression is indeed a subset of an anxiety disorder or whether it is something completely different.  We discussed this question from a scientific standpoint and from the observational standpoint of how different a depressed person looks from an anxious person.  I noted that there are different types of depression and often times a depressed person is also suffering from an anxiety disorder.

 

Some useful links to explore the HPA axis and the basis of anxiety disorders and depression:

http://www.answers.com/topic/hypothalamic-pituitary-adrenal-axis 

http://64.233.161.104/search?q=cache:gQPp7p3P6ogJ:people.uleth.ca/~r.mcdonald/mooddisorders.ppt+HPA+axis+depression+anxiety&hl=en&client=firefox-a

http://www.biopsychiatry.com/anxdep.htm

http://www.defeatdepression.org/pdf/cortisolstressdepression.pdf

http://joe.endocrinology-journals.org/cgi/content/short/160/1/1

http://www.dr-bob.org/babble/20000420/msgs/31619.html


            a.         Diagnostic criteria

                        i.         Self-fulfilling, e.g., ADHD
ADHD, or Attention Deficit Hyperactivity Disorder, causes extreme hyperactivity and inattentiveness, and can lead to severe problems for students and employees who must spend large amounts of time sitting still and paying attention.  Medicines such as Ritalin and Adderall can greatly help school aged children and adults increase their work capabilities and potential.  For those who do suffer from ADHD these medicines have enabled them to compete on an average level with their age group; however, average educational standards have been on the rise with each new generation and ADHD diagnoses similarly soaring.  Is this due to a more accurate prognosis of the disease or more emphasis being put upon lengthy attention spans and better grades?  Teachers are often among those to recommend children for ADHD testing and treatment, yet clearly teachers would benefit from a more focused and quiet classroom.  Not to mention, that ADHD medication has become one of the most widely abused drugs, especially among college students.  At what point should society draw the line… what does constitute a normal attention span?  Children and adults alike are being forced to withstand longer and longer amounts of time behind a desk.  Is ADHD medication our answer to this unnatural inactivity or should we take the more natural approach and realize that “kids will be kids”.
Here is a website for more information on the actual symptoms and treatment of ADHD:  http://www.nimh.nih.gov/publicat/adhd.cfm#symptoms

            b.         Treatments

                        i.         Psychopharmacology

                                    (1)       Unexpected side-effects

                                    (2)       Role of federal government and individual rights

                        ii.        Neuroprosthetics

                                    (1)       http://www.neuroethics.upenn.edu/nonpharme.html

                        iii.       Tissue implants and stem cells

             c.         Anxiety and depression

    Discussing the biology of mental and neurological disorders is quite an undertaking.  In fact, an entire semester of university credit is devoted to it in Vanderbilt’s psychology course entitled the Biological Basis of Mental Disorders.  Thus said, there is obviously no way to do the subject justice in one class period.  What we did attempt to undertake, however, is a brief description of the biology behind depression.  We used this as a springboard for a larger discussion on the ethics of mental disorders and the ethics of medications that treat depression, such as Prozac.  Is depression overdiagnosed?  Can a person without depression take Prozac and become happier?  Can a pill become the panacea for eliminating any feelings of pain or suffering? These are some of the questions pondered in relation to the topic.  Many of the questions that come to mind were not addressed in class, but will help the observer to think about this subject in a critical manner.

    The most recent hypothesis for the biological basis of depression that has been supported by the most evidence is the theory which implicates the hyperactivity of the HPA axis as the cause of depression.  The prefrontal cortex sends messages regarding its perceptions to the amygdala and the hypothalamus, some of the emotional processing centers of the brain.  In this schematic, the amygdala serves as a “revving up” of the hypothalamus and the resulting stress response while the hippocampus serves as a “calming down” of the hypothalamus and the stress response.  The stress response involves the release of corticotropin-releasing hormones, which prompts the release of adrenocorticpotropin hormone.  This travels through the blood as a hormone to the adrenal gland of the kidney and prompts the release of corticosteroids.  Normally, these corticosteroids that are released as a result of the stress response would travel through the body, attach to glucocorticoid receptors on the hippocampus, and activate the downregulation of the stress response.  Various theories exist as to why this does not happen, but somehow the binding on the hippocampus does not occur and the HPA axis is continually upregulated without being brought back down to resting state by the hippocampus.  The theory suggests that depression is a mood disorder regulated by stress and inherently tied to anxiety.

    We discussed whether or not we believed that depression is indeed a subset of an anxiety disorder or whether it is something completely different.  We discussed this question from a scientific standpoint and from the observational standpoint of how different a depressed person looks from an anxious person.  I noted that there are different types of depression and often times a depressed person is also suffering from an anxiety disorder.

    Some useful links to explore the HPA axis and the basis of anxiety disorders and depression:

http://www.answers.com/topic/hypothalamic-pituitary-adrenal-axis

http://www.biopsychiatry.com/anxdep.htm

http://www.defeatdepression.org/pdf/cortisolstressdepression.pdf

http://joe.endocrinology-journals.org/cgi/content/short/160/1/1

http://www.dr-bob.org/babble/20000420/msgs/31619.html

 

5.         Enhancement of normal function

            a.         What is normal?

                        i.         J. B. S. Haldane, DAEDALUS or Science and the Future. A paper read to the Heretics, Cambridge, on February 4th, 1923

                        ii.        Coercion, e.g., steroids in sports

                                    (1)       Financial incentives

                         iii. "The Bell Curve."
http://www.sfu.ca/~wwwpsyb/issues/1996/winter/keenan.htm

            b.         Mood & memory enhancement

                        i.         Farah MJ, Illes J, Cook-Deegan R, Gardner H, Kandel E, King P, Parens E, Sahakian B, Wolpe PR. Neurocognitive enhancement: what can we do and what should we do? Nat Rev Neurosci. 2004 May;5(5):421-5.

                        ii.        Dees RH. Slippery slopes, wonder drugs, and cosmetic neurology: the neuroethics of enhancement. Neurology. 2004 Sep 28;63(6):951-2

                        iii.       http://www.neuroethics.upenn.edu/pharmem.html

                        iv.       http://www.neuroethics.upenn.edu/pharmec.html

 

                         Drug addiction is different from physical dependence, although they often exist together.  The development of tolerance to a drug (having to take more of it to get the original result) also does not necessarily indicated drug addiction.  Further, the scientific definition of drug addiction is not influenced by the social acceptability of either the drug or addiction to it.  Addiction occurs when behavior to use or obtain a drug overrides normal motivations. 
    Two common theories are the Individual and Unitary approaches.  The former states that there are different mechanisms for different drugs, while the latter advocates a broad mechanism that exists across all drug types. 

(See http://www.mayoclinic.com/invoke.cfm?objectid=23246C2F-131D-4391-BB2A6B3E819A126F&dsection=3 for a review of different categories with an individual theory approach.)
   
    Discussion on the topic was broad.  It included the question of how much responsibility one holds while on drugs (To what extent should people be guilty if they commit crimes while on drugs?  To what extent is there scientific evidence supporting the fact that drug addiction might prohibit normal function, since we know there is a significant motivational change during addiction?) 
    Most of the time, however, was spent discussing drug use and addiction on Vanderbilt’s campus. An article in the Vanderbilt Hustler focusing on cocaine use on campus (http://www.vanderbilthustler.com/vnews/display.v/ART/2004/04/13/407b6f33ea24e?in_archive=1) was published last year (2004), and alcohol and tobacco use is high on Vanderbilt’s campus (not to say that any other schools are without them). 
    Most of the discussion focused on “kids will be kids” vs. “the law is the law” discussion.  A student in the class reported that the ResEd policy on drug use is actually illegal:  the police are not to be called, and the area director is to confiscate the drug (therefore being illegally in possession) and take it to be destroyed.  Such protective policies contribute to irresponsible drug and alcohol use among Vanderbilt students, but many parents (and teachers, who occasionally offer students alcohol at off-campus gatherings) seem to disregard Vanderbilt’s policy of no underage drinking.   

Helpful links:
http://www.mayoclinic.com/invoke.cfm?objectid=23246C2F-131D-4391-BB2A6B3E819A126F&dsection=1
http://wings.buffalo.edu/aru/ARUreport04.html
http://www.drugabuse.gov/PODAT/PODATindex.html
http://www.drugabuse.gov/Infofacts/HSYouthtrends.html

                        Here is a link on legalization arguments for drug addiction.  It's a long reading, but it's really interesting. 
http://www.psychedelic-library.org/drugsandrights.htm

            c.         Business

                        i.         Neuroeconomics

                                    (1)       Glimcher PW, Rustichini A. Neuroeconomics: the consilience of brain and decision. Science. 2004 Oct 15;306(5695):447-52.

                                    (2)       Zak PJ. Neuroeconomics. Philos Trans R Soc Lond B Biol Sci. 2004 Nov 29;359(1451):1737-48.

                                    (3)       http://www.neuroeconomics.net/

                        ii.        Neuroinvestment

                                    (1)       http://www.corante.com/brainwaves/

                                    (2)       http://www.neuroinvestment.com/

                        iii.       Neuromarketing

                                    (1)       http://www.wordspy.com/words/neuromarketing.asp

                                    (2)       http://www.pbs.org/wgbh/pages/frontline/shows/persuaders/etc/neuro.html

                                    (3)       http://www.commercialalert.org/index.php/category_id/1/subcategory_id/82/article_id/202

                        iv.       Memory drug companies

                                    (1)       Gary Lynch, Professor of Psychiatry at the University of California in Irvine, cofounder of Cortex Pharmaceuticals, Inc. (http://www.cortexpharm.com/)

                                    (2)       Mark Bear, Picower Center for Learning and Memory at MIT, cofounder of Helicon (http://www.helicontherapeutics.com/)

                                    (3)       Erik Kandel, Columbia University & Nobel Laureate cofounder of Memory Pharmaceuticals Corp. (http://www.memorypharma.com/)

6.         Neuroscience and the law

            a.        Some general resources
http://www.dana.org/books/press/danabook/neurolaw/

                         November 2004 issue of Philosophical Transactions: Biological Sciences issue on Law and the Brain
Including article by Erin O'Hara, Vanderbilt University School of Law

            b.         Rights of the

                        i.         Individual

                        ii.        Society

                        iii.       Species

            c.         Scientific evidence in the courts

                        i.         Daubert ruling

                                    (1)       http://www.daubertontheweb.com/

                        ii.        DNA testing

                        iii.       Brain fingerprinting

                                    (1)  Supporting its use

Farwell, Brain Fingerprinting Laboratories  
"Brain Fingerprinting Laboratories, Inc. has developed and patented EEG/P300 based testing systems that determine with extremely high accuracy whether or not specific information is stored in a person’s memory. The test measures individual brain-wave responses to relevant words, pictures or sounds presented by a computer. The measurements are recorded in fractions of a second after the stimulus is presented, before the subject is able to formulate or control a response. In a major milestone for the company, the results of this patented testing methodology have been ruled admissible in court as scientific evidence. The technology has many exciting applications in several very large markets: national security, medical diagnostics, advertising, insurance fraud and in the criminal justice system."

                                     (2) Questioning its use

                                                Center for Cognitive Liberty
"The CCLE is opposed to compulsory Brain Fingerprinting because it threatens cognitive liberty and violates the sanctity of the mind. Compelled Brain Fingerprinting intrudes on the individual's right to mental privacy, it should not be mandated by courts, governments, corporations, or any other institution."

            d.         Enforced medication of criminals

                        i.         Medicate to convict?
(1) The case of  Russell Weston Jr.
       http://muse.jhu.edu/journals/kennedy_institute_of_ethics_journal/v011/11.4cohen.html
       http://www.washingtonpost.com/wp-srv/national/longterm/shooting/stories/weston042399.htm
       http://www.washingtonpost.com/wp-srv/national/longterm/shooting/archives2.htm

                                     (2) Chemical castration of pedophiles
       Florida's Chemical Castration Law
       Larry Don McQuay

            e.         Evolution of human society

                        i.         Fitness

                        ii.        Basis of altruism

 

7.         Ethics of Research

            a.         Consent by impaired individuals

            b.         Animal use in research

            c.         Stem cell research
Stem cell information from NIH
Research ethics and stem cells from NIH
Monitoring Stem Cell Research, The President's Council on Bioethics
Basic human embryology
       Embryonic images
           Image of 7-12 day embryo
           Image of 13 day embryo

            d.         Should some discoveries by avoided?

 

8.         End of life
a. The Terry
Schiavo case.
http://abstractappeal.com/schiavo/infopage.html

9.         Other readings

            a.         Fukuyama, F. 2002. OUR POSTHUMAN FUTURE. Farrar, Strauss and Giroux.